Evidence map›Paper›PMID 27385416›Full record

ArticlePsychopharmacology2016

Alterations in alpha5* nicotinic acetylcholine receptors result in midbrain- and hippocampus-dependent behavioural and neural impairments.

Morgane Besson, Stefania Guiducci, Sylvie Granon, Jean-Philippe Guilloux, Bruno Guiard, Christelle Repérant, Philippe Faure, Stéphanie Pons, Giuseppe Cannazza, Michele Zoli and 2 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Psychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Concatemers to re-investigate the role of α5 in α4β2 nicotinic receptors.Cellular and molecular life sciences : CMLS · 2021
    Article
  7. Review
  8. TheArab journal of basic and applied sciences · 2020
    Article
  9. Profound alteration in reward processing due to a human polymorphism in CHRNA5: a role in alcohol dependence and feeding behavior.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2019
    Article
  10. Chrna5-Expressing Neurons in the Interpeduncular Nucleus Mediate Aversion Primed by Prior Stimulation or Nicotine Exposure.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 7 institutions in 2 countries.

Morgane BessonNeurobiologie Intégrative des Systèmes Cholinergiques, Département de Neuroscience, CNRS UMR 3571, Institut Pasteur, Paris, 75724 cedex15, France. morgane.besson@pasteur.fr.
Stefania GuiducciDepartment of Biomedical, Metabolic and Neural Sciences, Section of Physiology and Neurosciences, University of Modena and Reggio Emilia, Modena, 41121, Italy.
Sylvie GranonNeurobiologie de la Prise de Décision, Neuro-PSI, CNRS UMR 9197, Orsay, 91405, France.
Jean-Philippe GuillouxNeuropharmacologie des troubles anxieux-dépressifs et neurogénèse, Université Paris-Sud XI, Chatenay-Malabry, 91290, France.
Bruno GuiardNeuropharmacologie des troubles anxieux-dépressifs et neurogénèse, Université Paris-Sud XI, Chatenay-Malabry, 91290, France.
Christelle RepérantNeuropharmacologie des troubles anxieux-dépressifs et neurogénèse, Université Paris-Sud XI, Chatenay-Malabry, 91290, France.
Philippe FaureNeurobiologie des processus adaptatifs, Neurophysiologie et Comportement, Université Pierre et Marie Curie, Paris, 75005, France.
Stéphanie PonsNeurobiologie Intégrative des Systèmes Cholinergiques, Département de Neuroscience, CNRS UMR 3571, Institut Pasteur, Paris, 75724 cedex15, France.
Giuseppe CannazzaDepartment of Life Sciences, University of Modena and Reggio Emilia, Modena, 41121, Italy.
Michele ZoliDepartment of Biomedical, Metabolic and Neural Sciences, Section of Physiology and Neurosciences, University of Modena and Reggio Emilia, Modena, 41121, Italy.
Alain M GardierNeuropharmacologie des troubles anxieux-dépressifs et neurogénèse, Université Paris-Sud XI, Chatenay-Malabry, 91290, France.
Uwe MaskosNeurobiologie Intégrative des Systèmes Cholinergiques, Département de Neuroscience, CNRS UMR 3571, Institut Pasteur, Paris, 75724 cedex15, France.
Université Paris-Sud · FRUniversity of Modena and Reggio Emilia · ITCentre National de la Recherche Scientifique · FRInstitut Galien Paris-Saclay · FRInstitut Pasteur · FRLaboratoire de Neurobiologie Cellulaire et Moléculaire · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rationaleEvidence links alterations in α5-containing nicotinic receptors (α5*-nAChRs) to nicotine addiction. Notably, the rs16969968 polymorphism in the α5 gene (α5SNP) increases the risk for heavy smoking and impairs nicotine-rewarding properties in mice. Additional work is needed to understand how native and polymorphic α5*-nAChRs contribute to processes associated with the risk for nicotine addiction.

objectivesWe aimed at understanding the contribution of α5*-nAChRs to endophenotypes like increased responses to novelty and anxiety, known to promote vulnerability to addiction, and to the response of the dopamine and serotonin systems to nicotine.

methodsBehavioural phenotypes were investigated in mice lacking the α5 gene (α5(-/-)). Nicotine injections were performed to test the consequences of nicotine exposure on the phenotypes identified. Dopamine and serotonin signalling were assessed using in vivo microdialysis and electrophysiology. We used lentiviral vectors to compare the consequences of re-expressing either the α5 wild-type allele or the α5SNP in specific brain areas of α5(-/-) mice.

resultsα5(-/-) mice did not exhibit high responses to novelty but showed decreased novelty-induced rearing behaviour together with high anxiety. Exposure to high doses of nicotine rescued these phenotypes. We identified altered spontaneous and nicotine-elicited serotonin and dopamine activity in α5(-/-) mice. Re-expression of α5 in the ventral tegmental area and hippocampus rescued rearing and anxiety levels in α5(-/-) mice, respectively. When expressing the α5SNP instead, this resulted in a knockout-like phenotype for both behaviours.

conclusionsWe propose that altered α5*-nAChR cholinergic signalling contributes to emotional/behavioural impairments that may be alleviated by nicotine consumption.

Indexed as

AnimalsAnxietyBehavior, AnimalBrainDopamineExploratory BehaviorHippocampusMaleMesencephalonMiceMice, KnockoutMicrodialysisNicotineNicotinic AgonistsPolymorphism, Single NucleotideReceptors, NicotinicCHRNA5 protein, mouseDopamineNicotineNicotinic AgonistsReceptors, NicotinicSerotoninAddictionAnxietyLentiviral vectorMiceMonoaminesNicotineNicotinic receptorsNoveltyPolymorphismVulnerability

Identifiers

PMID27385416
OpenAlexW2461356587

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.